Epigenetic mechanisms in Alzheimer's disease: Progress but much to do

Neurobiology of Aging

Volumn 32, Issue 7, 2011, Pages 1181-1187

  Balazs, Robert ^a   Vernon, Jeffrey ^b   Hardy, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; DNA methylation; Epigenetics; Gene expression; Genetics

Indexed keywords

ANTIDEPRESSANT AGENT; DNA METHYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE INHIBITOR; SIRTUIN; VALPROIC ACID;

AGING; ALZHEIMER DISEASE; DNA METHYLATION; DRUG INHIBITION; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC REGULATION; HISTONE ACETYLATION; HUMAN; LIFESTYLE MODIFICATION; NONHUMAN; NOTE; PRIORITY JOURNAL;

AGING; ALZHEIMER DISEASE; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 79958763443     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.02.024     Document Type: Note

References (65)

1. Barrachina M., Ferrer I. DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J. Neuropathol. Exp. Neurol 2009, 68:880-891.
2. Barroso E., Eyre E., Palomer X., Vázquez-Carrera M. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1. Biochem. Pharmacol 2010, 81:534-543.
3. Basha M.R., Wei W., Bakheet S.A., Benitez N., Siddiqi H.K., Ge Y.W., Lahiri D.K., Zawia N.H. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J. Neurosci 2005, 25:823-829.
4. Bjornsson H.T., Sigurdsson M.I., Fallin M.D., Irizarry R.A., Aspelund T., Cui H., Yu W., Rongione M.A., Ekström T.J., Harris T.B., Launer L.J., Eiriksdottir G., Leppert M.F., Sapienza C., Gudnason V., Feinberg A.P. Intra-individual change over time in DNA methylation with familial clustering. JAMA 2008, 299:2877-2883.
5. Brohede J., Rinde M., Winblad B., Graff C. A DNA methylation study of the amyloid precursor protein gene in several brain regions from patients with familial Alzheimer disease. J. Neurogenet 2010, 24:179-181.
6. Canettieri G., Morantte I., Guzmán E., Asahara H., Herzig S., Anderson S.D., Yates J.R., Montminy M. Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nat. Struct. Biol 2003, 10:175-181.
7. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., Zoghbi H.Y. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
8. Champagne F.A., Weaver I.C., Diorio J., Dymov S., Szyf M., Meaney M.J. Maternal care associated with methylation of the estrogen receptor-alpha1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring. Endocrinology 2006, 147:2909-2915.
9. Chouliaras L., Sierksma A.S., Kenis G., Prickaerts J., Lemmens M.A., Brasnjevic I., van Donkelaar E.L., Martinez-Martinez P., Losen M., De Baets M.H., Kholod N., van Leeuwen F., Hof P.R., van Os J., Steinbusch H.W., van den Hove D.L., Rutten B.P.2010. Gene-environment interaction research and transgenic mouse models of Alzheimer's disease. Int. J. Alzheimers Dis 2010, pii: 859101.
10. Costa F.F. Non-coding RNAs: Meet thy masters. Bioessays 2010, 32:599-608.
11. Day J.J., Sweatt J.D. DNA methylation and memory formation. Nat. Neurosci 2010, 13:1319-1323.
12. Donmez G., Wang D., Cohen D.E., Guarente L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 2010, 142:320-332.
13. Fischer A., Sananbenesi F., Wang X., Dobbin M., Tsai L.H. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007, 447:178-182.
14. Fischer A., Sananbenesi F., Mungenast A., Tsai L.H. Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol. Sci 2010, 31:605-617.
15. Gao J., Siddoway B., Huang Q., Xia H. Inactivation of CREB mediated gene transcription by HDAC8 bound protein phosphatase. Biochem. Biophys. Res. Commun 2009, 379:1-5.
16. Guan J.S., Haggarty S.J., Giacometti E., Dannenberg J.H., Joseph N., Gao J., Nieland T.J., Zhou Y., Wang X., Mazitschek R., Bradner J.E., DePinho R.A., Jaenisch R., Tsai L.H. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009, 459:55-60.
17. Haigis M.C., Sinclair D.A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol 2010, 5:253-295.
18. Halagappa V.K., Guo Z., Pearson M., Matsuoka Y., Cutler R.G., Laferla F.M., Mattson M.P. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Dis 2007, 26:212-220.
19. Heijmans B.T., Tobi E.W., Stein A.D., Putter H., Blauw G.J., Susser E.S., Slagboom P.E., Lumey L.H. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17046-17049.
20. Hooker J.M., Kim S.W., Alexoff D., Xu Y., Shea C., Reid A., Volkow N., Fowler J.S. Histone deacetylase inhibitor, MS-275, exhibits poor brain penetration: PK studies of [C]MS-275 using Positron Emission Tomography. ACS Chem. Neurosci 2010, 1:65-73.
21. Jiang Y., Matevossian A., Huang H.S., Straubhaar J., Akbarian S. Isolation of neuronal chromatin from brain tissue. BMC Neurosci 2008, 9:42.
22. Julien C., Tremblay C., Emond V., Lebbadi M., Salem N., Bennett D.A., Calon F. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J. Neuropathol. Exp. Neurol 2009, 68:48-58.
23. Kilgore M., Miller C.A., Fass D.M., Hennig K.M., Haggarty S.J., Sweatt J.D., Rumbaugh G. Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 2010, 35:870-880.
24. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 2007, 26:3169-3179.
25. Kim D., Frank C.L., Dobbin M.M., Tsunemoto R.K., Tu W., Peng P.L., Guan J.S., Lee B.H., Moy L.Y., Giusti P., Broodie N., Mazitschek R., Delalle I., Haggarty S.J., Neve R.L., Lu Y., Tsai L.H. Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 2008, 60:803-817.
26. Ladd-Acosta C., Pevsner J., Sabunciyan S., Yolken R.H., Webster M.J., Dinkins T., Callinan P.A., Fan J.B., Potash J.B., Feinberg A.P. DNA methylation signatures within the human brain. Am. J. Hum. Genet 2007, 81:1304-1315.
27. Lane A.A., Chabner B.A. Histone deacetylase inhibitors in cancer therapy. J. Clin. Oncol 2009, 27:5459-5468.
28. Lasalle J.M., Yasui D.H. Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics 2009, 1:119-130.
29. Levenson J.M., O'Riordan K.J., Brown K.D., Trinh M.A., Molfese D.L., Sweatt J.D. Regulation of histone acetylation during memory formation in the hippocampus. J. Biol. Chem 2004, 279:40545-40559.
30. Liang W.S., Dunckley T., Beach T.G., Grover A., Mastroeni D., Ramsey K., Caselli R.J., Kukull W.A., McKeel D., Morris J.C., Hulette C.M., Schmechel D., Reiman E.M., Rogers J., Stephan D.A. Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology. Neurobiol. Aging 2010, 31:549-566.
31. Lubin F.D., Roth T.L., Sweatt J.D. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J. Neurosci 2008, 28:10576-10586.
32. Mastroeni D., McKee A., Grover A., Rogers J., Coleman P.D. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One 2009, 4:e6617.
33. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol. Aging 2010, 31:2025-2037.
34. Mattick J.S., Makunin I.V. Non-coding RNA. Hum. Mol. Genet. 15 Spec No 2006, 1:R17-R29.
35. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonté B., Szyf M., Turecki G., Meaney M.J. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci 2009, 12:342-348.
36. Murayama A., Ohmori K., Fujimura A., Minami H., Yasuzawa-Tanaka K., Kuroda T., Oie S., Daitoku H., Okuwaki M., Nagata K., Fukamizu A., Kimura K., Shimizu T., Yanagisawa J. Epigenetic control of rDNA loci in response to intracellular energy status. Cell 2008, 133:627-639.
37. Murgatroyd C., Patchev A.V., Wu Y., Micale V., Bockmühl Y., Fischer D., Holsboer F., Wotjak C.T., Almeida O.F., Spengler D. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat. Neurosci 2009, 12:1559-1566.
38. Murgatroyd C., Wu Y., Bockmühl Y., Spengler D. The Janus face of DNA methylation in aging. Aging (Albany N. Y.) 2010, 2:107-110.
39. Noureen N., Rashid H., Kalsoom S. Identification of type-specific anticancer histone deacetylase inhibitors: road to success. Cancer Chemother Pharmacol 2010, 66:625-633.
40. Pandey G.N., Ren X., Rizavi H.S., Conley R.R., Roberts R.C., Dwivedi Y. Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacology 2008, 11:1047-1061. http://www.ncbi.nlm.nih.gov/pubmed/18611289.
41. Peleg S., Sananbenesi F., Zovoilis A., Burkhardt S., Bahari-Javan S., Agis-Balboa R.C., Cota P., Wittnam J.L., Gogol-Doering A., Opitz L., Salinas-Riester G., Dettenhofer M., Kang H., Farinelli L., Chen W., Fischer A. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010, 328:753-756.
42. Penner M.R., Roth T.L., Barnes C.A., Sweatt J.D. An epigenetic hypothesis of aging-related cognitive dysfunction. Front. Aging Neurosci 2010, 2:9.
43. Qin W., Yang T., Ho L., Zhao Z., Wang J., Chen L., Zhao W., Thiyagarajan M., MacGrogan D., Rodgers J.T., Puigserver P., Sadoshima J., Deng H., Pedrini S., Gandy S., Sauve A.A., Pasinetti G.M. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem 2006, 281:21745-21754.
44. Qin W., Zhao W., Ho L., Wang J., Walsh K., Gandy S., Pasinetti G.M. Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration. Ann. N. Y. Acad. Sci 2008, 1147:335-347.
45. Rai K., Huggins I.J., James S.R., Karpf A.R., Jones D.A., Cairns B.R. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 2008, 135:1201-1212.
46. Rai M., Soragni E., Chou C.J., Barnes G., Jones S., Rusche J.R., Gottesfeld J.M., Pandolfo M. Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model. PLoS One 2010, 5:e8825.
47. Rai M., Soragni E., Jenssen K., Burnett R., Herman D., Coppola G., Geschwind D.H., Gottesfeld J.M., Pandolfo M. HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS One 2008, 3:e1958.
48. Rasouri S., Lagouge M., Auwerx J. SIRT1/PGC-1: a neuroprotective axis?. Med. Sci. (Paris) 2007, 23:840-844. [in French].
49. Renthal W., Nestler E.J. Chromatin regulation in drug addiction and depression. Dialogues Clin. Neurosci 2009, 11:257-268.
50. Ricobaraza A., Cuadrado-Tejedor M., Marco S., Perez-Otano I., Garcia-Osta A. Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus 2010, Epub ahead of print.
51. Ricobaraza A., Cuadrado-Tejedor M., Perez-Mediavilla A., Frechilla D., Del R.J., Garcia-Osta A. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 2009, 34:1721-1732.
52. Roth T.L., Lubin F.D., Funk A.J., Sweatt J.D. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol. Psychiatry 2009, 65:760-769.
53. Schindowski K., Belarbi K., Buée L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav 2008, 7(Suppl 1):43-56.
54. Siegmund K.D., Connor C.M., Campan M., Long T.I., Weisenberger D.J., Biniszkiewicz D., Jaenisch R., Laird P.W., Akbarian S. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One 2007, 2:e895.
55. Suzuki M.M., Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet 2008, 9:465-476.
56. Tian F., Hu X.Z., Wu X., Jiang H., Pan H., Marini A.M., Lipsky R.H. Dynamic chromatin remodeling events in hippocampal neurons are associated with NMDA receptor-mediated activation of Bdnf gene promoter. J. Neurochem 2009, 1:109. 1375-1388.
57. Tohgi H., Utsugisawa K., Nagane Y., Yoshimura M., Genda Y., Ukitsu M. Reduction with age in methylcytosine in the promoter region - 224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res. Mol. Brain Res 1999, 70:288-292.
58. Tohgi H., Utsugisawa K., Nagane Y., Yoshimura M., Ukitsu M., Genda Y. The methylation status of cytosines in a tau gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex. Neurosci. Lett 1999, 275:89-92.
59. Vaquero A., Scher M., Erdjument-Bromage H., Tempst P., Serrano L., Reinberg D. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature 2007, 450:440-444.
60. Waddington C. The Epigenome. Endeavour 1942, 1:18-20.
61. Wang J., Fivecoat H., Ho L., Pan Y., Ling E., Pasinetti G.M. The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology. Biochim. Biophys. Acta 2010, 1804:1690-1694.
62. Wang S.C., Oelze B., Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS One 2008, 3:e2698.
63. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., Dymov S., Szyf M., Meaney M.J. Epigenetic programming by maternal behavior. Nat. Neurosci 2004, 7:847-854.
64. Wu J., Basha M.R., Brock B., Cox D.P., Cardozo-Pelaez F., McPherson C.A., Harry J., Rice D.C., Maloney B., Chen D., Lahiri D.K., Zawia N.H. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J. Neurosci 2008, 28:3-9.
65. Wu J., Basha M.R., Zawia N.H. The environment, epigenetics and amyloidogenesis. J. Mol. Neurosci 2008, 34:l-7.